Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhangbiao Long

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Cell and Developmental Biology|February 6, 2026
Evolution and mechanistic insights of platelet-derived products in temporomandibular joint regenerationCong Lin, Yutong Jin, Dan Li, et al.
Frontiers in Oncology|June 27, 2022
Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19Chengxin Luan, Haixia Wang, Junjie Zhou, et al.
British Journal of Haematology|July 31, 2025
Differential modulation of Bruton's tyrosine kinase inhibitor selectivity on platelet GPVI and integrin αIIbβ3 bidirectional signalling via BTK/PLCγ2/PKCθ affects haemostasis and thrombosisTeng Zhang, Shan Du, Gongwei Han, et al.
Annals of Hematology|November 16, 2019
Correction to: prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuriaYuzhou Huang, Xinjian Liu, Fangfei Chen, et al.
Annals of Hematology|August 10, 2019
Prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuriaYuzhou Huang, Xinjian Liu, Fangfei Chen, et al.
Scientific Reports|January 24, 2025
Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levelsRuonan Shao, Danchen Meng, Beibei Gao, et al.
American Journal of Hematology|March 17, 2025
Cyclophosphamide Abrogates Immune Effector Cell-Associated Neurotoxicity Syndrome Associated With CAR-T Cell TherapyZhengfeng Hou, Yanli Jiang, Yi Fu, et al.
Frontiers in Oncology|December 12, 2022
Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case reportJing Ni, Junjie Zhou, Zhangbiao Long, et al.
Clinical Therapeutics|June 14, 2025
Safety and Efficacy of Grapefruit Juice Combined With Low-Dose Venetoclax in AML Patients Ineligible for Intensive ChemotherapyDanchen Meng, YuXin Li, Min Ruan, et al.
Immunotherapy|October 7, 2024
A lesson from fatal invasive fungal infections after CAR-T cell therapy: a case report and literature reviewZhengfeng Hou, Danchen Meng, Min Ruan, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Cell and Developmental Biology|February 6, 2026
Evolution and mechanistic insights of platelet-derived products in temporomandibular joint regenerationCong Lin, Yutong Jin, Dan Li, et al.
Frontiers in Oncology|June 27, 2022
Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19Chengxin Luan, Haixia Wang, Junjie Zhou, et al.
British Journal of Haematology|July 31, 2025
Differential modulation of Bruton's tyrosine kinase inhibitor selectivity on platelet GPVI and integrin αIIbβ3 bidirectional signalling via BTK/PLCγ2/PKCθ affects haemostasis and thrombosisTeng Zhang, Shan Du, Gongwei Han, et al.
Annals of Hematology|November 16, 2019
Correction to: prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuriaYuzhou Huang, Xinjian Liu, Fangfei Chen, et al.
Annals of Hematology|August 10, 2019
Prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuriaYuzhou Huang, Xinjian Liu, Fangfei Chen, et al.
Scientific Reports|January 24, 2025
Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levelsRuonan Shao, Danchen Meng, Beibei Gao, et al.
American Journal of Hematology|March 17, 2025
Cyclophosphamide Abrogates Immune Effector Cell-Associated Neurotoxicity Syndrome Associated With CAR-T Cell TherapyZhengfeng Hou, Yanli Jiang, Yi Fu, et al.
Frontiers in Oncology|December 12, 2022
Anti-CD19 chimeric antigen receptor T-cell followed by interferon-α therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case reportJing Ni, Junjie Zhou, Zhangbiao Long, et al.
Clinical Therapeutics|June 14, 2025
Safety and Efficacy of Grapefruit Juice Combined With Low-Dose Venetoclax in AML Patients Ineligible for Intensive ChemotherapyDanchen Meng, YuXin Li, Min Ruan, et al.
Immunotherapy|October 7, 2024
A lesson from fatal invasive fungal infections after CAR-T cell therapy: a case report and literature reviewZhengfeng Hou, Danchen Meng, Min Ruan, et al.
Pageof 5